These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 4391647)

  • 21. A test to measure the immunosuppressive potency of antilymphocyte sera.
    Saleh WS; MacLean LD; Gordon J; Lamoureux G
    Transplantation; 1969 Oct; 8(4):524-6. PubMed ID: 4392843
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphocyte environment and the durability of transplantation tolerance.
    Levey RH
    Transplant Proc; 1972 Sep; 4(3):395-9. PubMed ID: 4404152
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of DL-A matching, ALS, and 24-hour preservation on isolated pancreas allograft survival.
    de Gruyl J; Westbroek DL; Dijkhuis CM; Vriesendorp HM; MacDicken I; Elion-Gerritsen W; Verschoor L; Hulsmans HA; Hörchner P
    Transplant Proc; 1973 Mar; 5(1):755-9. PubMed ID: 4572138
    [No Abstract]   [Full Text] [Related]  

  • 24. The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma.
    Jeejeebhoy HF
    Transplantation; 1967 Jul; 5(4):Suppl:1121-6. PubMed ID: 4963509
    [No Abstract]   [Full Text] [Related]  

  • 25. The place of heterologous antilymphocytic globulin in renal transplantation.
    Clunie GJ
    Med J Aust; 1969 Jun; 1(26):1368-70. PubMed ID: 4898052
    [No Abstract]   [Full Text] [Related]  

  • 26. [Orthotopic transplantation of the liver in dogs (50 cases). Trial use of antilymphocyte serum].
    Moreaux J; Huguet C; Hugier M; Martin E; Bloch P
    Nouv Presse Med; 1972 Jan; 1(5):338. PubMed ID: 4551595
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunosuppressive therapy in experimental and clinical liver transplantation].
    Lie TS
    Zentralbl Chir; 1970 Aug; 95(34):1001-8. PubMed ID: 4943409
    [No Abstract]   [Full Text] [Related]  

  • 28. [Organ transplantation United States, 1969].
    Greep JM; van der Heyde MN; Wildevuur CR
    Ned Tijdschr Geneeskd; 1970 Feb; 114(7):299-302. PubMed ID: 4905553
    [No Abstract]   [Full Text] [Related]  

  • 29. The future of transplantation biology and medicine.
    Medawar P
    Transplant Proc; 1969 Mar; 1(1):666-9. PubMed ID: 4944283
    [No Abstract]   [Full Text] [Related]  

  • 30. Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum.
    Floersheim GL; Brune K
    Transplant Proc; 1971 Mar; 3(1):688-92. PubMed ID: 4398510
    [No Abstract]   [Full Text] [Related]  

  • 31. The immunosuppressive activity of ara-C (cytarabine) and derivatives.
    Gray GD
    Transplant Proc; 1973 Sep; 5(3):1203-9. PubMed ID: 4147026
    [No Abstract]   [Full Text] [Related]  

  • 32. [Signification and problems in the study of organ transplantation].
    Picardi N
    Ann Ital Chir; 1970; 46(3):380-6. PubMed ID: 4403124
    [No Abstract]   [Full Text] [Related]  

  • 33. [Liver transplantation].
    Mikaeloff P
    Bull Soc Int Chir; 1967 Sep; 26(5):489-95. PubMed ID: 4913603
    [No Abstract]   [Full Text] [Related]  

  • 34. Antihuman lymphoblast globulin.
    Najarian JS; Simmons RL; Gewurz H; Moberg A; Merkel F; Moore GE
    Fed Proc; 1970; 29(1):197-201. PubMed ID: 4189495
    [No Abstract]   [Full Text] [Related]  

  • 35. Prolongation of skin allograft survival with antilymphocyte serum and soluble histocompatibility antigens.
    Sumerska T; Betel I; Balner H; Warren HS
    Transplantation; 1974 Jan; 17(1):1-7. PubMed ID: 4148888
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental study on the effect of antilymphocyte sera].
    Dubernard JM; Mikaeloff P; Bomel J; Rassat JP
    J Med Lyon; 1970 Jan; 51(178):9-35. PubMed ID: 4949850
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanism of permanent survival of canine renal allografts following a limited course of ALS treatment.
    Shanfield I; Wolf JS; Wren SF; MacLean LD; Hume DM
    Transplant Proc; 1973 Mar; 5(1):533-4. PubMed ID: 4572113
    [No Abstract]   [Full Text] [Related]  

  • 38. Allograft survival after treatment with antilymphocyte serum combined with immunosuppressive drugs.
    Grogan JB; Shivers BR
    Surgery; 1969 Dec; 66(6):1085-9. PubMed ID: 4394173
    [No Abstract]   [Full Text] [Related]  

  • 39. Antilymphocyte serum and the induction of tolerance to transplantation antigens.
    Lance EM; Medawar PB
    Fed Proc; 1970; 29(1):151-2. PubMed ID: 4391648
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on time-dependence of immunosuppressive effects of antilymphocyte serum in vivo and in vitro.
    Nouza K; Haskovcova H; Sejkorova J; Nemec M
    Transplant Proc; 1971 Mar; 3(1):803-6. PubMed ID: 4398513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.